Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
D000818:Animals; D001681:Biological Assay; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D010451:Peptide PHI; D010455:Peptides; D051381:Rats; D012633:Secretin / Q000494:pharmacology*; D013270:Stomach / Q000187:drug effects; D013329:Structure-Activity Relationship; D013552:Swine; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D005768:Gastrointestinal Hormones; D010451:Peptide PHI; D010455:Peptides; D012633:Secretin; D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP